Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The United States Trotting Association, which in late September dropped out of the Racing Medication and Testing Consortium and rejected model medication rules approved by RCI, has created its own drug advisory committee.
The United States Trotting Association, citing differences in breeds, said Sept. 26 it has ended its membership in the Racing Medication and Testing Consortium and has rejected the proposed national model drug rules.
Most Popular Stories
- Promising Mastery Heads Los Al Futurity Field
- Del Mar to Pay Out Consolations for Pick 6
- End of Road for ‘Claiming Rule’ Challenge
- Woolf Award Finalists Announced
- Lukas Drops by to See Old Friend Charismatic
- Casse Mulls Derby Path for Classic Empire
- Thoroughbred Makeover Accepting Applications
- Bowman Wins Hong Kong Jockey Championship
- Greatbullsoffire Tops Futurity
- Innovative Wagers Help Racetracks with Handle